PY990158A - Nucleosidos terapeuticos - Google Patents

Nucleosidos terapeuticos

Info

Publication number
PY990158A
PY990158A PY199909900158A PY990158A PY990158A PY 990158 A PY990158 A PY 990158A PY 199909900158 A PY199909900158 A PY 199909900158A PY 990158 A PY990158 A PY 990158A PY 990158 A PY990158 A PY 990158A
Authority
PY
Paraguay
Prior art keywords
treatment
nucleosides
therapeutic nucleosides
purine
carbovir
Prior art date
Application number
PY199909900158A
Other languages
English (en)
Inventor
Mary Daluge Susan
Original Assignee
The Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Wellcome Foundation Ltd filed Critical The Wellcome Foundation Ltd
Publication of PY990158A publication Critical patent/PY990158A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a análogos de nucleósidos de purina que contienen un anillo carbocíclico insaturado en lugar del resto de azúcar, derivados farmacéuticamente aceptables de los mismos y su uso en terapia médica, concretamente para el,tratamiento de ciertas infecciones virales.El documento FR-A-2626002 describe determinados isómeros ópticamente activos de nucleósidos de purina carbocíclicos, entre los que se incluye de carbovir,y su uso en el tratamiento del virus VIH carbovir.
PY199909900158A 1999-02-12 1999-12-17 Nucleosidos terapeuticos PY990158A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9903091.8A GB9903091D0 (en) 1999-02-12 1999-02-12 Therapeutic nucleoside compound

Publications (1)

Publication Number Publication Date
PY990158A true PY990158A (es) 2001-12-03

Family

ID=10847550

Family Applications (1)

Application Number Title Priority Date Filing Date
PY199909900158A PY990158A (es) 1999-02-12 1999-12-17 Nucleosidos terapeuticos

Country Status (15)

Country Link
US (1) US6630477B1 (es)
EP (1) EP1150981B1 (es)
JP (1) JP2002536448A (es)
KR (1) KR20010102081A (es)
CN (1) CN1346356A (es)
AT (1) ATE237616T1 (es)
AU (1) AU2450900A (es)
DE (1) DE60002172T2 (es)
DK (1) DK1150981T3 (es)
ES (1) ES2195861T3 (es)
GB (1) GB9903091D0 (es)
HK (1) HK1039935B (es)
PT (1) PT1150981E (es)
PY (1) PY990158A (es)
WO (1) WO2000047581A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2210373C1 (ru) * 2002-07-03 2003-08-20 Государственное учреждение Тверская государственная медицинская академия Способ лечения тяжелого и затяжного течения острого вирусного гепатита
WO2007148083A2 (en) * 2006-06-21 2007-12-27 Ge Healthcare As Stabilisation of radiopharmaceutical precursors
WO2019099595A1 (en) * 2017-11-14 2019-05-23 The Schepens Eye Research Institute, Inc. NANO-EMULSION OF CBFβ-RUNX1 INHIBITOR FOR OCULAR DRUG DELIVERY

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2793825B2 (ja) * 1988-01-20 1998-09-03 リージヤンツ・オブ・ザ・ユニバーシテイ・オブ・ミネソタ ジデオキシジデヒドロ炭素環式ヌクレオシド
US4916224A (en) * 1988-01-20 1990-04-10 Regents Of The University Of Minnesota Dideoxycarbocyclic nucleosides
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
DE68907013D1 (de) 1988-10-24 1993-07-15 Wellcome Found Guaninderivate mit antiviraler wirkung und deren pharmazeutisch vertraegliche salze.
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
EP0468119A1 (en) * 1990-07-24 1992-01-29 Merrell Dow Pharmaceuticals Inc. Novel carbocyclic analogs of certain nucleosides
JPH06199812A (ja) * 1991-02-12 1994-07-19 Takeda Chem Ind Ltd 新規シクロペンテン誘導体
GB9417249D0 (en) 1994-08-26 1994-10-19 Wellcome Found A novel salt

Also Published As

Publication number Publication date
JP2002536448A (ja) 2002-10-29
WO2000047581A1 (en) 2000-08-17
DE60002172T2 (de) 2003-11-27
GB9903091D0 (en) 1999-03-31
HK1039935A1 (en) 2002-05-17
DK1150981T3 (da) 2003-07-21
EP1150981A1 (en) 2001-11-07
AU2450900A (en) 2000-08-29
DE60002172D1 (de) 2003-05-22
KR20010102081A (ko) 2001-11-15
HK1039935B (en) 2003-12-19
US6630477B1 (en) 2003-10-07
ES2195861T3 (es) 2003-12-16
EP1150981B1 (en) 2003-04-16
CN1346356A (zh) 2002-04-24
ATE237616T1 (de) 2003-05-15
PT1150981E (pt) 2003-08-29

Similar Documents

Publication Publication Date Title
ES2087639T3 (es) Nucleosidos terapeuticos.
ES2054693T3 (es) Compuestos antivirales.
ES2069582T3 (es) Nucleosidos terapeuticos.
FI20001231A7 (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
ES2147294T3 (es) Compuestos terapeuticos.
MX9204474A (es) Analogos nucleosidos 1,3-oxatiolano.
UY27875A1 (es) Prodrogas 2 ' y 3 ' de nucleósidos modificados para tratar flaviviridae
ES2065914T3 (es) Nucleosidos terapeuticos.
ES2091750T3 (es) Compuestos antivirales.
PA8588501A1 (es) Derivados antivirales de nucleósidos
MX9204454A (es) Derivados de tiourea para inhibir la replicacion del virus de inmunodeficiencia humana y formulado farmaceutico que los contiene.
WO1993017020A3 (en) Therapeutic nucleosides
ES2157929T3 (es) Beta-d-dioxolano-nucleosidos enantiomeramente puros.
ES2177695T3 (es) Uso de derivados funcionales de la molecual de adhesion intercelular icam-1 en terapia antiviral.
ES2061453T3 (es) Composiciones farmaceuticas antivirales que contienen hipericina o pseudohipericina.
ES2138969T3 (es) Combinacion de nucleosidos antivirales.
ES2133138T3 (es) Nucleosidos terapeuticos.
TR200102313T2 (tr) Antiviral maddeler olarak (1R, SíS)-4-(6-amino-9H-purin-9-il)-2-siklopenten-1-metanoln mono-, di ve tri-fosfat esterleri ve fosforamidatlarì
DK0777669T3 (da) 4-[2-amino-6-(cyclopropylamino)-9H-purin-yl]-2-cyclopenten-1-methanolsuccinat som antiviralt middel
UY25004A1 (es) Hemisulfato de nucleósido carbocíclico para uso en el tratamiento de infecciones virales
AR022250A1 (es) Envase farmaceutico de uso para el tratamiento y prevencion de infecciones por el virus de la hepatitis b, procedimiento para el tratamiento de pacientes o pacientes susceptibles en padecer infecciones por el virus de la hepatitis b.
PY990158A (es) Nucleosidos terapeuticos
ES2052922T3 (es) Nucleosidos terapeuticos.
ES2101747T3 (es) Penciclovir y famciclovir y derivados de guanina relacionados para el tratamiento de infecciones por vih-1.
PY970077A (es) Nucleosidos terapeuticos